| Estrace (estradiol) / AbbVie |
| Completed | 4 | 120 | US | transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium) | Northwestern University, University of Washington | Menopause, Postmenopause, Premenopause, Cardiovascular Disease | | 05/05 | | |
NCT00837616: Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism |
|
|
| Completed | 4 | 41 | US, RoW | 17 B estradiol orally, Estrace, 17 B estradiol, Vivelle | Nemours Children's Clinic, Genentech, Inc. | Turner Syndrome, Hypogonadism, Premature Ovarian Failure | 06/12 | 12/12 | | |
NCT03493126: Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function |
|
|
| Completed | 4 | 59 | US | Estradiol, Estrace, Placebo | Ohio State University, International Urogynecological Association | Vaginal Atrophy | 09/20 | 09/20 | | |
NCT03943823: Postmenopausal Pessary Users: Estrogen Versus Trimosan |
|
|
| Terminated | 4 | 4 | US | Estrogen vaginal cream, Estrace Cream, Premarin Cream, Trimo-San vaginal gel, Trimo-San | The University of Texas Health Science Center, Houston | Vaginosis, Vaginosis, Bacterial, Vaginal Discharge | 03/21 | 04/21 | | |
| Withdrawn | 4 | 0 | US | Estradiol 2 mg, Estrace, Placebo | Emory University | Cystic Fibrosis Related Bone Disease | 06/21 | 06/21 | | |
NCT05221021: Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome |
|
|
| Recruiting | 4 | 152 | US | Vaginal estrogen, Estrace, Estradiol, Micronized Estrogen, Mirabegron 50 MG [Myrbetriq], Myrbetriq | Walter Reed National Military Medical Center | Overactive Bladder Syndrome | 12/26 | 01/27 | | |
NCT05317364: Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery |
|
|
| Recruiting | 4 | 50 | US | Estradiol 0.01% Vag Cream, Estrace cream, Placebo vaginal cream, Versabase vaginal cream | University of Alabama at Birmingham | Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence | 01/26 | 07/26 | | |
NCT01886794: Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse |
|
|
| Terminated | 4 | 7 | US | Postmenopausal, topical vaginal estrogen cream, Estrace vaginal cream, Placebo Comparator: Postmenopausal, topical placebo cream, Placebo vaginal cream | The University of Texas Medical Branch, Galveston | Pelvic Floor Disorders | 12/23 | 12/23 | | |
NCT04933240: Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial |
|
|
| Withdrawn | 4 | 0 | US | Tamoxifen Citrate 10Mg Tab, NOLVADEX, Estradiol, ESTRACE, Placebo, Inactive drug | Virginia Commonwealth University | Vaginal Bleeding | 06/24 | 12/24 | | |
NCT06353269: Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections |
|
|
| Recruiting | 4 | 111 | US | Estring Vaginal Product, Vagifem, Estrace 0.01% Vaginal Cream | University of California, Irvine | Recurrent Urinary Tract Infection, Hypoestrogenism | 01/27 | 10/27 | | |
